Balanced news tone
News Sentiment
INCR sentiment intelligence
InterCure Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
19 relevant articles
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-11.0% over one week, +11.0% over four weeks, trend inactive, and below fair value.
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% Amid Uncertain Revenue Picture - Energy Earnings Report
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
80/100 classification
One-week reaction
-11.0%
Price reacting lower
Trend fit
Trend inactive
11.0% over four weeks
Fair value
-37.5%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
14
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
dars.gov.et
Direct company coverage
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% Amid Uncertain Revenue Picture - Energy Earnings Report
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 24 Jun 2026 07:00
- Source
- dars.gov.et
Stock Titan
Direct company coverage
InterCure raises NIS 22M, with room to reach NIS 54M
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Quiver Quantitative
Direct company coverage
InterCure Secures NIS 22 Million Private Placement With Potential to Rise to NIS 54 Million for Global Expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Quiver Quantitative
GlobeNewswire
Direct company coverage
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
InterCure (NASDAQ: INCR) lines up NIS 22–54 million private placement funding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
TradingKey
Direct company coverage
InterCure Ltd (INCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 21:27
- Source
- TradingKey
MT Newswires
Direct company coverage
InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 14:00
- Source
- MT Newswires
GlobeNewswire
Direct company coverage
InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 13:25
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
U.S. cannabis shift prompts InterCure rethink and new launches in Germany
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
GlobeNewswire
Direct company coverage
InterCure Initiates Strategic Review of U.S. Medical
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 07:00
- Source
- GlobeNewswire
Quiver Quantitative
Direct company coverage
InterCure Ltd. Completes First Tranche of Botanico Acquisition to Enhance International Medical Cannabis Platform
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 07:00
- Source
- Quiver Quantitative
dars.gov.et
Direct company coverage
Intercure Ltd. (INCR) Holds Near Support as Modest Gains Signal Stabilization Attempt - PCR Extreme
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- dars.gov.et
DonanımHaber
Direct company coverage
Intercure Ltd. (INCR) Rallies 5.57% as It Approaches Key Resistance Level - Rating Change
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 27 May 2026 07:00
- Source
- DonanımHaber
GlobeNewswire
Direct company coverage
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- GlobeNewswire
Quiver Quantitative
Direct company coverage
Intercure LTD (INCR) Releases Q4 2025 Earnings: Revenue Up 43.8% but Company Remains Unprofitable
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Quiver Quantitative
GlobeNewswire
Direct company coverage
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Mar 2026 08:00
- Source
- GlobeNewswire
Cannabis Business Times
Direct company coverage
InterCure to Acquire ISHI, Unlocking Access to Premium US Cannabis Technology, Brands
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Sep 2025 07:00
- Source
- Cannabis Business Times
Mugglehead Investment Magazine
Direct company coverage
InterCure to distribute Mike Tyson’s cannabis internationally
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2023 07:00
- Source
- Mugglehead Investment Magazine
The Business Journals
Direct company coverage
Longtime leader of INC Research retires suddenly
Jim Ogle, who led INC Research since 2003, has announced his sudden retirement as board chairman. INC Research (Nasdaq: INCR) is a pharmaceutical research group based in Raleigh. This news comes amidst other developments in the CRO sector.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2016 11:30
- Source
- The Business Journals